Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas

World Journal of Surgery

Volumn 28, Issue 8, 2004, Pages 787-791

  Huo, Teh Ia ^a   Wu, Jaw Ching ^a   Hsia, Cheng Yuan ^a   Chau, Gar Yang ^a   Lui, Wing Yiu ^a   Huang, Yi Hsiang ^a   Lee, Pui Ching ^a   Chang, Full Young ^a   Lee, Shou Dong ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS NON A NON B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PERSISTENT VIRUS INFECTION; RECURRENCE RISK; RISK FACTOR; TUMOR RECURRENCE; TUMOR VOLUME; VERTICAL TRANSMISSION; VIRUS HEPATITIS; VIRUS INFECTION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK; RISK FACTORS;

EID: 4744358580     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-7320-9     Document Type: Article

References (38)

1. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35:519-524
2. Hussain SA, Ferry DR, El-Gazzaz G, et al. Hepatocellular carcinoma. Ann. Oncol. 2001;12:161-172
3. Kawasaki S, Makuuchi M, Miyagawa S, et al. Results of hepatic resection for hepatocellular carcinoma. World J. Surg. 1995;19:31-34
4. Shirabe K, Kanematsu T, Matsumata T, et al. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analysis. Hepatology 1991;14:802-805
5. Jwo SC, Chiu JH, Chau GY, et al. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992;16:1367-1371
6. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993;105:488-494
7. Izumi R, Shimizu K, Li T, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994;106:720-727
8. Chen MF, Jeng LB, Lee WC. Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan. World J. Surg. 2002;26:742-747
9. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin. Liver Dis. 1999;19:311-322
10. Mc Peake JR, O'Grady JG, Zaman S, et al. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determined outcome. J. Hepatol. 1993;18:226-234
11. Huang YH, Wu JC, Chau GY, et al. Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patients. J. Gastroenterol. 1998;33:512-516
12. Kubo S, Nishiguchi S, Hirohashi K, et al. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma: a randomized, controlled trial. Ann. Intern. Med. 2001;134:963-967
13. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. J. Hepatol. 2001;35:421-430
14. Edmonson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503
15. Rizzi PM, Kane PA, Ryder SD, et al. Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation. Gastroenterology 1994;107:1425-1429
16. Shuto T, Hirohashi K, Ikebe T, et al. Additional hepatocellular carcinomas undetectable before surgery. World J. Surg. 2000;24:1566-1569
17. Ko S, Nakajima Y, Kanehiro H, et al. Influence of associated viral hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. World J. Surg. 1996;20:1082-1086
18. Camma C, Giunta M, Andreone P, et al. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J. Hepatol. 2001;34:593-602
19. Gramenzi A, Andreone P, Fiorino S, et al. Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis. Gut 2001;48:843-848
20. Moriyama Y, Nishiguchi S, Tamori A, et al. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma. Clin. Cancer Res. 2001;7:1293-1298
21. Lai CL, Lau JY, Wu PC, et al. Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial. Hepatology 1993;17:389-394
22. Mallat DB, El-Serag HB. Interferon: benefit beyond hepatitis therapy? Am. J. Gastroenterol. 2001;96:3435-3436
23. Kotoh K, Sakai H, Sakamoto S, et al. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am. J. Gastroenterol. 1994;89:194-198
24. Huo TI, Huang YH, Wu JC, et al. Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. Ann. Oncol. 2003;14:1648-1653
25. Ohto M, Yoshikawa M, Saisho H, et al. Nonsurgical treatment of hepatocellular carcinoma in cirrhotic patients. World J. Surg. 1995;19:42-46
26. Huo TI, Huang YH, Wu JC, et al. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective controlled study. Scand. J. Gastroenterol. 2003;38:770-778
27. Unsal H, Yakicier C, Marcais C, et al. Genetic heterogeneity of hepatocellular carcinoma. Proc. Natl. Acad. Sci. U. S. A. 1994;91:822-826
28. Su Q, Schroder CH, Hofmann WJ, et al. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 1998;27:1109-1120
29. Paterlini P, Poussin K, Kew M, et al. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995;21:313-321
30. Lo KJ, Tsai YT, Lee SD, et al. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J. Infect. Dis. 1985;152:817-822
31. Chen TZ, Wu JC, Yen FS, et al. Injection with non-disposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan. J. Med. Virol. 1995;46:247-251
32. Curry GW, Beattie AD. Pathogenesis of primary hepatocellular carcinoma. Eur. J. Gastroenterol. Hepatol. 1996;8:850-855
33. Di Marco V, Lo Iacono O, Camma C, et al. The long-term course of chronic hepatitis B. Hepatology 1999;30:257-264
34. Schoniger-Hekele M, Muller C, Kutilek M, et al. Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation. Eur. J. Gastroenterol. Hepatol. 2000;12:941-948
35. Chu CM, Yeh CT, Sheen IS, et al. Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV. Gut 2002;51:95-99
36. Fukuda R, Ishimura N, Niigaki M, et al. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J. Med. Virol. 1999;58:201-207
37. Liaw YF, Tsai SL, Sheen IS, et al. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers. Am. J. Gastroenterol. 1998;93:354-359
38. Huo TI, Wu JC, Lee PC, et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998;28:231-236